We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$14.1B
1-Year Est. Return
30.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.91%
1 Year Est. Return
+30.11%
3 Year Est. Return
+110.39%
5 Year Est. Return
+152.15%
10 Year Est. Return
+370.53%
AUM
$14.1B
AUM Growth
+$741M
(+5.6%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
11.22%
Top 10 Holdings %
Top 10 Hldgs %
38.76%
Holding
1,735
New
165
Increased
1,464
Reduced
57
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$110M |
| 2 |
Apple
AAPL
|
+$89M |
| 3 |
Microsoft
MSFT
|
+$81.1M |
| 4 |
Amazon
AMZN
|
+$54.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$45.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Principal Financial Group
PFG
|
+$4.8M |
| 2 |
KeyCorp
KEY
|
+$4.08M |
| 3 |
SOLS
Solstice Advanced Materials
SOLS
|
+$3.06M |
| 4 |
Valero Energy
VLO
|
+$2.61M |
| 5 |
Monster Beverage
MNST
|
+$2.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.95% |
| 2 | Financials | 11.04% |
| 3 | Consumer Discretionary | 10.63% |
| 4 | Communication Services | 10.59% |
| 5 | Healthcare | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Geron
GERN
$924M
| $72K | ﹤0.01% |
48,319
+5,398
| +13% | +$8.21K |
|
1602
Butterfly Network
BFLY
$1.75B
| $71.9K | ﹤0.01% |
17,803
+2,509
| +16% | +$9.69K |
|
1603
Savara
SVRA
$1.13B
| $69.6K | ﹤0.01% |
12,746
+1,756
| +16% | +$9.77K |
|
|
RWT
1604
Redwood Trust
RWT
$626M
| $69.1K | ﹤0.01% |
12,323
+1,519
| +14% | +$8.81K |
|
1605
Talkspace
TALK
$873M
| $67.7K | ﹤0.01% |
13,075
+1,806
| +16% | +$7.99K |
|
1606
MannKind Corp
MNKD
$1.23B
| $67.3K | ﹤0.01% |
27,486
+3,668
| +15% | +$16.4K |
|
1607
American Express Global Business Travel
GBTG
$4.91B
| $66.8K | ﹤0.01% |
11,963
-1,453
| -11% | -$9.02K |
|
1608
Empire State Realty Trust
ESRT
$966M
| $65.8K | ﹤0.01% |
12,662
+1,426
| +13% | +$8.56K |
|
1609
LegalZoom.com
LZ
$1.32B
| $65.6K | ﹤0.01% |
11,572
+1,495
| +15% | +$11.3K |
|
|
BRSP
1610
BrightSpire Capital
BRSP
$694M
| $65.2K | ﹤0.01% |
11,649
+1,547
| +15% | +$8.96K |
|
1611
Ambev
ABEV
$47.6B
| $65K | ﹤0.01% |
22,266
+2,489
| +13% | +$7.11K |
|
1612
Clover Health Investments
CLOV
$2.37B
| $65K | ﹤0.01% |
36,915
+4,900
| +15% | +$10.6K |
|
1613
ACV Auctions
ACVA
$1.29B
| $64.4K | ﹤0.01% |
15,190
+2,014
| +15% | +$13.2K |
|
1614
Ardagh Metal Packaging
AMBP
$2.69B
| $64.4K | ﹤0.01% |
15,896
+1,672
| +12% | +$7.41K |
|
1615
CEMIG Preferred Shares
CIG
$6.15B
| $64.4K | ﹤0.01% |
26,930
+2,443
| +10% | +$5.38K |
|
1616
Clarivate
CLVT
$1.49B
| $64.3K | ﹤0.01% |
25,413
+7,097
| +39% | +$18.2K |
|
1617
Stagwell
STGW
$1.84B
| $63.7K | ﹤0.01% |
+10,126
| New | +$56.6K |
|
1618
Janus International
JBI
$719M
| $63.4K | ﹤0.01% |
12,306
+1,626
| +15% | +$10.5K |
|
1619
Precigen
PGEN
$1.81B
| $63.3K | ﹤0.01% |
16,352
+2,161
| +15% | +$8.87K |
|
1620
SELLAS Life Sciences
SLS
$2.45B
| $62.7K | ﹤0.01% |
+14,817
| New | +$66.3K |
|
1621
Compass Therapeutics
CMPX
$364M
| $62.6K | ﹤0.01% |
11,836
+1,635
| +16% | +$9.44K |
|
1622
Annexon
ANNX
$913M
| $62.1K | ﹤0.01% |
+11,206
| New | +$63.1K |
|
1623
Arbutus Biopharma
ABUS
$871M
| $61.6K | ﹤0.01% |
13,690
+1,814
| +15% | +$7.93K |
|
1624
PureCycle Technologies
PCT
$1.22B
| $61.2K | ﹤0.01% |
11,783
+1,557
| +15% | +$13K |
|
1625
Sprinklr
CXM
$1.39B
| $60.9K | ﹤0.01% |
+10,155
| New | +$63K |
|
Similar funds
CM
ETC
BIP
FGP
BPC
SSA
TI
BBVA
Xponance's Q1 2026 Portfolio in Review
As of Q1 2026, Xponance held 1,735 positions worth $14.1B, up 5.6% from $13.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Xponance deployed $1.58B of net new capital in Q1 2026, opening 165 new positions and adding to 1,464 existing holdings. Its largest new stake was Medline Inc: 22,732 shares worth $1.01M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Principal Financial Group, an estimated $4.8M trimmed.
- Xponance's largest Q1 2026 buy was Medline Inc: 22,732 shares worth $1.01M.
- Xponance added most to NVIDIA in Q1 2026, an estimated $110M increase.
- Xponance's biggest Q1 2026 reduction was Principal Financial Group, cutting an estimated $4.8M.
- Xponance fully exited Confluent in Q1 2026, selling an estimated $1.34M.
- Xponance's ten largest holdings make up 39% of its $14.1B portfolio in Q1 2026.
- Xponance opened 165 new positions and closed 49 in Q1 2026.
- Xponance's portfolio value rose 5.6% quarter-over-quarter to $14.1B.
Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.